Study Summary:
Axis Clinical Trials is currently having, two paid Hepatitis C studies. There is one study, which is a year long study, which attempts at treating Hep C.
The second study is a 45 day, healthier liver study.
Qualified Participants Must:
Have never been treated for Hep C
Not have moderate to severe Cirrhosis
Be willing to have a biopsy, if never have had one before
HIV, Hep B, Hx Cancer in the last 5 years
Qualified Participants May Receive:
Up to $1060 or up to $1070. Persons are paid in payments, throughout the study.